Sleep 3
Natural health product licensed in Canada
- Other names
- Deep Sleep, Good Night, Good Sleep, Sleep Ease, Sleep III, Sleep Well, Sleep three
- Licence holder
- Nestle Canada Inc. dba (Atrium Innovations/Genestra Brands/Pure Encapsulations/Garden of Life Canada/Trophic Canada/SISU/Wobenzym/Bountiful Canada Vitamins/Nature's Bounty/Vital Proteins Canada)
- NPN or DIN-HM
- 80095920
- Status
- Active licence
- Licence date
- 4 December 2019
- Revision date
- 13 August 2024
- Form
- Tablet, modified release
- Route of administration
- Orale
- Application type
- Générale (non traditionelle)
If this product were sold in France
- Conditions légales
Valeriana officinalis L.: L'absence de valépotriates doit être prouvée par des rapports d'analyse. L'étiquetage doit comporter un avertissement déconseillant l'emploi aux enfants de moins de 12 ans.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Melissa officinalis L. (Lamiaceae) Source : Melissa officinalis - Herb top Extract : Matériel brut sec Extraction ratio : 8:1 Dry plant equivalent : 120 mg | 15 mg | Not calculated |
| Valeriana officinalis Source : Racine Extract : Matériel brut sec Extraction ratio : 8:1 Dry plant equivalent : 40 mg | 5 mg | Not calculated |
| Matricaria chamomilla Source : Fleur Extract : Matériel brut sec Extraction ratio : 8:1 Dry plant equivalent : 120 mg | 15 mg | Not calculated |
| L-théanine Source : Synthétique | 200 mg | Not calculated |
| N-acétyl-5-méthoxytryptamine Source : Mélatonine | 10 mg | Not calculated |
Non-medicinal ingredients
Croscarmellose de sodium, Glycérol, Silice, Stéarate de magnésium, Cellulose, Phosphate dicalcique, Acide stéarique, Jus de légumes, Hypromellose
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19 years | 1 Comprimé | 1 Tous les jours |
Uses authorised in Canada
Helps to temporarily promote relaxation. Helps increase the total sleep time (aspect of sleep quality) in people suffering from sleep restriction or altered sleep schedule (e.g. shift-work and jet lag). Helps re-set the body's sleep-wake cycle (aspect of the circadian rhythm). Helps re-set the body's sleep-wake cycle (aspect of the circadian rhythm) and increase the total sleep time (aspect of sleep quality) in people suffering from sleep restriction or altered sleep schedule (e.g. shift work and jet lag). Helps re-set the body's sleep-wake cycle (aspect of the circadian rhythm) and prevent and/or reduce the effects of jet lag/minimize jet lag (e.g. daytime fatigue, sleep disturbance) (for people travelling by plane easterly across two or more time zones/if flying east over two or more time zones). Helps to prevent and/or reduce the effects of jet lag/minimize jet lag (e.g. daytime fatigue, sleep disturbance) (for people travelling by plane easterly across two or more time zones/if flying east over two or more time zones). Helps to speed up/ reduce the time it takes to fall asleep (sleep onset latency aspect of sleep quality) in people who fall asleep slowly/ with delayed sleep phase disorder.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Contre-indications
Do not use this product if you are pregnant or breastfeeding.
- Effets indésirables connus
Stop use if allergy occurs or if you experience headache, confusion, or nausea. Stop use if hypersensitivity/allergy occurs.
Source
Official Health Canada record, licence 80095920
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2024. Photograph the packaging to check whether it has changed. Photograph the packaging